搜索临床试验以:新抗原 mRNA 疫苗
总计6838个结果
-
Stemirna TherapeuticsPeking University Cancer Hospital & Institute尚未招聘晚期恶性实体瘤
-
Shanghai Jiao Tong University School of Medicine招聘中
-
SENAI CIMATEC招聘中
-
National Institute of Allergy and Infectious Diseases...PPD完全的
-
Tan Tock Seng HospitalKK Women's and Children's Hospital; Duke-NUS Graduate Medical School; A*Star招聘中
-
University of FloridaUniversity of California, San Francisco; Florida Department of Health; Pacific Pediatric Neuro-Oncology... 和其他合作者招聘中
-
Sheba Medical CenterModernaTX, Inc.完全的
-
International AIDS Vaccine InitiativeEmory University; Fred Hutchinson Cancer Center; George Washington University; ModernaTX, Inc.; UT...主动,不招人
-
Karolinska University HospitalKarolinska Institutet主动,不招人
-
Sanofi Pasteur, a Sanofi Company终止
-
City of Hope Medical CenterNational Cancer Institute (NCI)招聘中
-
Duke UniversityWashington University School of Medicine; University of Pittsburgh; Centers for Disease Control... 和其他合作者主动,不招人
-
Sunnybrook Health Sciences CentreUniversity Health Network, Toronto; Unity Health Toronto; Scarborough General Hospital; Providence...终止
-
ANRS, Emerging Infectious DiseasesLinKinVax; Vaccine Research Institute (VRI), France尚未招聘
-
CNBG-Virogin Biotech (Shanghai) Ltd.Shulan (Hangzhou) Hospital招聘中
-
AIM Vaccine Co., Ltd.Ningbo Rongan Biological Pharmaceutical Co. Ltd.; LiveRNA Therapeutics Inc.尚未招聘SARS-CoV-2
-
Judit Pich Martínez完全的
-
University of LiegePfizer招聘中
-
Sanofi Pasteur, a Sanofi Company完全的
-
AIM Vaccine Co., Ltd.First Affiliated Hospital Bengbu Medical College; Ningbo Rongan Biological Pharmaceutical Co...主动,不招人
-
Mayo Clinic终止
-
ModernaTX, Inc.完全的流感 | SARS-CoV-2 | 呼吸道合胞病毒英国, 澳大利亚, 美国
-
National Institute of Allergy and Infectious Diseases...完全的
-
Centre Hospitalier Universitaire de Saint EtienneSanofi Pasteur, a Sanofi Company; Bioster, a.s.完全的
-
Chulalongkorn UniversityBioNet-Asia; Chula Clinical Research Center (Chula CRC), Faculty of Medicine, Chulalongkorn... 和其他合作者招聘中25 ug ChulaCov19-BNA159 mRNA 疫苗的安全性 | 25 ug ChulaCov19-BNA159 mRNA 疫苗的耐受性 | 25 ug ChulaCov19-BNA159 mRNA 疫苗的免疫反应 | 50 ug ChulaCov19-BNA159 mRNA 疫苗的安全性 | 50 ug ChulaCov19-BNA159 mRNA 疫苗的耐受性 | 50 ug ChulaCov19-BNA159 mRNA 疫苗的免疫反应 | 评估哪种剂量适合使用泰国
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...完全的新冠肺炎 | 疫苗不良反应 | 疫苗反应 | 肝移植;并发症 | 肺移植;并发症 | 疫苗反应受损 | 疫苗接种意大利